Novo Nordisk’s GLP-1 Pill Makes Key Progress
Novo Nordisk's pill, oral semaglutide, has scored approval for slashing cardiovascular risks, further confirming its health benefits beyond diabetes treatment.
Browsing Tag
business news
France Eyed as Europe’s New ‘Bad Boy’: Could a Technocratic…
Facing political turmoil, France is urged to consider a technocratic government, as political deadlock continues…
Projected $10.8 Billion Spent on Midterm Ads, Largest in History: AdImpact
Political ad spending during the 2025-2026 midterm season is expected to hit a record $10.8 billion, marking the…
Preview of Next Week’s Top Business and Financial Stories on CNBC
CNBC's Courtney Reagan previews next week's potential top business and financial stories. Share article via Facebook, Twitter.
Doximity Acquires AI Startup Pathway Medical for $63M to Boost Clinical Tools
Doximity acquires AI startup Pathway Medical for $63M to enhance clinical reference tooling and answer doctors'…
Understanding Trump’s ‘One Big Beautiful Bill Act’: Tax Changes…
Speaker Mike Johnson signs the One Big Beautiful Bill Act, as financial advisors analyze its impact on tax returns…
Explore Personal Finance and More with CNBC’s Various Platforms
Explore personal finance with CNBC: join the panel, learn about supply chain values, participate in investment clubs and more.
Trump’s Health Care Bill Risks Coverage for Millions, Threatens Rural…
Trump's "big, beautiful bill" plans sweeping changes to U.S. healthcare, potentially leaving millions uninsured and…
Debt Influencing Career Choices and Job Hunting, According to Survey
Many Americans are influenced by their debts when making career choices and job hunting, with 38% taking on a…
Trump’s Criticisms of Fed Chair Powell Signal Possible Change in Leadership
Jerome Powell's position as Federal Reserve Chair is under threat as President Trump considers his potential successors.